|Bid||0.7750 x 1100|
|Ask||0.7900 x 1400|
|Day's range||0.7425 - 0.7970|
|52-week range||0.6000 - 3.6800|
|Beta (5Y monthly)||2.09|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||18 Dec 2012|
|1y target est||N/A|
We can readily understand why investors are attracted to unprofitable companies. For example, although...
We feel now is a pretty good time to analyse Spectrum Pharmaceuticals, Inc.'s ( NASDAQ:SPPI ) business as it appears...
Thank you for joining us today for Spectrum Pharmaceuticals first quarter 2022 financial results conference call. Joining me on the call today from Spectrum Pharmaceuticals will be Tom Riga, president and CEO; and Dr. Francois Lebel, chief medical officer.